Role of ulinastatin in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: The Emperor's new clothes or Aladdin's magic lamp?

Pancreas

Volumn 39, Issue 8, 2010, Pages 1231-1237

  Chen, Suyu ^a   Shi, Hong ^b   Zou, Xiaoping ^c   Luo, Hesheng ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

^c THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

Author keywords

endoscopic retrograde cholangiopancreatography; hyperamylasemia; pancreatitis; ulinastatin

Indexed keywords

GABEXATE; PLACEBO; ULINASTATIN;

ABSENCE OF SIDE EFFECTS; ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; HYPERAMYLASEMIA; META ANALYSIS; PANCREATITIS; POST ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY PANCREATITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; GLYCOPROTEINS; HUMANS; HYPERAMYLASEMIA; PANCREATITIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRYPSIN INHIBITORS;

EID: 78049306021     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181dc67e7     Document Type: Article

References (24)

1. Wang P, Li ZS, Liu F, et al. Risk factors for ERCP-related complications: a prospective multicenter study. Am J Gastroenterol. 2009;104:31-40.
2. Tsujino T, kawabe T, Omata M. Antiproteases in preventing post-ERCP acute pancreatitis. JOP. 2007;8(suppl 4):509-517.
3. Cheon YK, Cho KB, Watins JL, et al. Efficacy of diclofenac in the prevention of post-ERCP pancreatitis in predominantly high-risk patients: a randomized double-blind prospective trial. Gastrointest Endosc. 2007;66:1126-1132.
4. Dai HF, Wang XW, Zhao K. Role of nonsteroidal anti-inflammatory drugs in the prevention of post-ERCP pancreatitis: a meta-analysis. Hepatobilliary Pancreat Dis Int. 2009;8:11-16.
5. Bai Y, Xu C, Yang X, et al. Glyceryl trinitrate for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: a meta-analysis of randomized, double-blind, placebo controlled trials. Endoscopy. 2009;41:690-695.
6. Andriulli A, Leandro G, Federici T, et al. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis. Gastrointest Endosc. 2007;65:624-632.
7. Bang UC, NLjgaard C, Andersen PK, et al. Meta-analysis: nitroglycerin for prevention of post-ERCP pancreatitis. Aliment Pharamacol Ther. 2009;29:1078-1085.
8. Yoo JW, Ryu JK, Lee SH, et al. Preventive effects of ulinastatin on post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a prospective, randomized, placebo-controlled trial. Pancreas. 2008;37:366-370.
9. Ueki T, Otani K, Kawamoto K, et al. Comparison between ulinastatin and gabexate mesylate for the prevention of postYendoscopic retrograde cholangiopancreatography pancreatitis: prospective, randomized, trial. J Gastroenterol. 2007;42:161-167.
10. Fujishiro H, Adachi K, Imaoka T, et al. Ulinastatin shows preventive effect on postYendoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study. J Gastroenterol Hepatol. 2006;21:1065-1069.
11. Tsujino T, Komasto Y, Isayama H, et al. Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial. Clin Gastroenterol Hepatol. 2005;3:376-383.
12. Gong P,Wang ZY, Tai PJ, et al. Prevention and treatment for post ERCP pancreatitis [in Chinese]. J Hepatobiliary Surg. 2004;12:101-103.
13. Song AL, Yin LN, Kou ZM. Preventive effects of ulinastatin on post ERCP hyperamylasemia and acute pancreatitis [in Chinese]. J Lanzhou Univ (Med Sci). 2005;31:24-25 switched to 40.
14. Chen XT, Fei ZY, Shen YF, et al. Clinical observation on ulinastatin for the prevention of post-ERCP pancreatitis [in Chinese]. Shandong Med J. 2005;45:44-45.
15. Inoue KI, Takano H, Shimada A, et al. Urinary trypsin inhibitor protects against systemic inflammation induced by lipopolysaccharide. Mol Pharmacol. 2005;67:673-680. (Pubitemid 40365315)
16. Ma T, Kang C, Shao H, et al. Protective effects of ulinastatin on proliferation and cytokine release of splenocytes from rats with severe acute pancreatitis. Euro Surg Res. 2006;38:445-450.
17. Uemura K, Murakami Y, Hayashidani Y, et al. Randomized clinical trial to assess the efficacy of ulinastatin for postoperative pancreatitis following pancreaticoduodenectomy. J Surg Oncol. 2008;5:309-313.
18. Sherman S, Alazmi WM, Lehman GA, et al. Evaluation of recombination platelet-activating factor acetylhydrolase of reducing the incidence and severity of post-ERCP pancreatitis. Gastrointest Endosc. 2009;69(3 pt 1):462-472.
19. Reddy SC, Draganov PV. ERCP wire systems: the long and the short of it. World J Gastroenterol. 2009;15:55-60.
20. Lee TH, Park do H, Park JY, et al. Can wire-guided cannulation prevent post-ERCP pancreatitis? A prospective randomized trial. Gastrointest Endosco. 2009;69:444-449.
21. Ito K, Fujita N, Noda Y, et al. Pancreatic guidewire placement for achieving selective biliary cannulation during endoscopic retrograde cholangio-pancreatography. World J Gastroenterol. 2008;14: 5595-5560.
22. Rabenstein T, Hanhn EG. Post-ERCP pancreatitis: new momentum. Endoscopy. 2002;34:325-329.
23. Badalov N, Tenner S, Baillie J. The prevention, recognition and treatment of post-ERCP pancreatitis. JOP. 2009;10:88-97.
24. NLjgaard C, Hornum M, Elkjaer M, et al. Does glyceryl nitrate prevent post-ERCP pancreatitis? A prospective, randomized, double-blind, placebo-controlled multicenter trial. Gastrointest Endosc. 2009;69: e31-e37.